SQL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (13 Nov 2023 @ 15:56):

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies...

Stats
Today's Volume	19 345.00
Average Volume	83 648.00
Market Cap	2.51M
EPS	$-3.20 ( 2023-11-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.402
ATR14	$1.548 (29.49%)

Insider Trading

Date	Person	Action	Amount	type
2022-08-17	Pfeffer David	Buy	16 332	Common Stock
2022-08-17	Milos Patrice M.	Buy	8 800	Common Stock
2022-12-09	Jones Daniel Robert	Buy	5 733	Common Stock
2022-12-19	Miscoll Douglas Patrick	Buy	1 500	Common Stock
2022-12-19	Miscoll Douglas Patrick	Buy	1 500	Common Stock

INSIDER POWER
100.00
Last 31 transactions
Buy: 740 419 \| Sell: 110 811

Volume Correlation

Long: 0.16 (neutral)

Short: 0.49 (neutral)

Signal:(39.429) Neutral

SeqLL Inc. Correlation

10 Most Positive Correlations
RMRM	0.899
TDAC	0.871
GAINL	0.863
PAIC	0.859
NTEC	0.853
SVOK	0.849
MSGM	0.841
TLGT	0.837
NVFY	0.834
SVAC	0.831

10 Most Negative Correlations
BOCH	-0.902
SHSP	-0.9
NETE	-0.898
MMAC	-0.86
DSPG	-0.842

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

SeqLL Inc. Correlation - Currency/Commodity

-0.43
( neutral )

-0.25
( neutral )

-0.55
( weak negative )

0.77
( moderate )

-0.04
( neutral )

-0.08
( neutral )

SeqLL Inc. Financials

Annual	2022
Revenue:	$1 177.00
Gross Profit:	$487.00 (41.38 %)
EPS:	$-14.11

Q3	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-3.33

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-4.03

Q1	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-5.16

Financial Reports:

No articles found.

SeqLL Inc.

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.